Partial EMT takes the lead in cancer metastasis
- PMID: 34875220
- DOI: 10.1016/j.devcel.2021.11.012
Partial EMT takes the lead in cancer metastasis
Abstract
In this issue of Developmental Cell, Lüönd et al. developed a tracing system, using the uncharacterized early epithelial-mesenchymal transition (EMT)-marker Tenascin C, to monitor cells undergoing partial EMT during malignant mammary cancer progression. They find that partial, but not full, EMT contributes to metastasis and that full EMT contributes to chemoresistance.
Copyright © 2021 Elsevier Inc. All rights reserved.
Comment on
-
Distinct contributions of partial and full EMT to breast cancer malignancy.Dev Cell. 2021 Dec 6;56(23):3203-3221.e11. doi: 10.1016/j.devcel.2021.11.006. Epub 2021 Nov 29. Dev Cell. 2021. PMID: 34847378
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
